Trump eyes possible coronavirus treatments at White House briefing
President Trump highlighted potential therapies for COVID-19 including chloroquine and remdesivir, with Roche and Gilead expanding studies. Other approaches such as convalescent plasma and actemra are under review, while scientists urge rigorous trials to confirm safety and effectiveness.
MENTIONED IN THIS ARTICLE
Donald Trump
White House
Trump
Food and Drug Administration
Stephen Hahn
Gilead Sciences
Roche
U.S
Hahn
Bayer
World Health Organization
Ross McKinney Jr
Association of American Medical Colleges
Gilead
Europe
Japan
United States
National Institutes of Health
Anthony Fauci
China
Fauci
Asia
Daniel Kuritzkes
Brigham and Women’s Hospital
Boston
Kuritzkes
New England Journal of Medicine
Volunteers test experimental vaccine to fight virus in Seattle
In Seattle three early vaccine volunteers describe why they joined the study to advance a possible shot against COVID-19. They show resilience at home, work remotely, and balance family lives while the trial tests different dosages and monitors for side effects.
MENTIONED IN THIS ARTICLE
Seattle
Associated Press
Microsoft
University of Washington
Jennifer Haller
Washington State
Haller
Neal Browning
Bothell
Washington
Browning
Rebecca Skull
Boston
Institute For Health Metrics and Evaluation
Also Mentioned on This Page
Genentech
FDA
Regeneron Pharmaceuticals
Fujifilm Toyama Chemical
Kaiser Permanente Washington Research Institute
Skull
Crouse Street
Akron
Free
Environmental Services
Phiomasonichome.org
Ern R
Whuere
Nettleton Rd
Medina